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ABSTRACT 
 
The improper and uncontrolled uses of antibiotics against pathogenic bacteria have resulted in 
the occurrence of Multi Drugs Resistant (MDR) strains. There is now an urgency to find alternative 
antibiotics to combat the MDR strains. Sponge associated microorganisms are among of the most 
interesting and promising marine natural product sources, which produce polyketide and non 
ribosomal peptide products with various biological activities. In this study, marine bacteria were 
isolated from sponge Aaptos sp. collected from North Java Sea, and were screened for antibacterial 
activity against MDR strains. Three out of 64 bacterial isolates were successfully screened and were 
found to be active against MDR strains, in which 2 isolates (SPA1 and SPA5) were active against 
resistant strain Escherichia coli and 1 isolate (SPA21) against resistant strain Proteus sp., respectively. 
These active isolates were also capable of amplifying NRPS gene fragments necessary for the 
biosynthesis of non ribosomal peptides. The identification results revealed that the active isolates are 
Halomonas aquamarina, Alpha proteobacterium, and Pseudoalteromonas luteviolacea 
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INTRODUCTION 
 
Sponges (phylum Porifera) are most 
primitive of the multicelled animals that 
have existed for 700–800 million years. Of 
the approximately 15,000 sponge species, 
most occur in marine environments. Only 
about 1% of the species inhabits freshwater 
(Belarbi et al, 2003). 
It has been known that sponges 
produce secondary metabolites to repel and 
deter predators (Pawlik et al., 2002), 
compete for space with other sessile species 
(Davis et al., 1991; Becerro et al., 1997), 
and for communication and protection 
against infection. In addition, potentially 
therapeutic compounds identified in sponges 
include anticancer agents and 
immunomodulators. Some sponges seem to 
produce potentially useful antifouling agents 
(Hellio et al., 2005). 
Recent research progresses reported 
that many bioactive natural products from 
marine invertebrates have striking 
similarities to metabolites of their associated 
microorganisms including bacteria (Proksch 
et al, 2002; Thiel and Imhoff, 2003; Radjasa 
et al, 2007a).  
The improper and uncontrolled uses of 
antibiotics have resulted in the occurrence 
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antimicrobial resistance, which become a 
major health problem world wide 
(Goldmann and Huskins, 1997). In the 
context of Indonesian population, a recent 
work by Kuntaman et al (2005) confirmed 
the occurrence of Fluoroquinolone-resistant 
Escherichia coli   based on population 
survey of 3.996 persons. There is now an 
urgency more than ever to find alternative 
antibiotics to combat the Multi Drugs 
Resistant (MDR) strains.  
Thus, it is important to highlight the 
possible role of marine bacteria associated 
with sponges in providing solution to the 
problem of infection by pathogenic bacteria 
in particular Multi Drugs Resistant (MDR) 
strains. 
Advanced techniques of molecular 
biology such as Polymerase Chain Reaction 
(PCR), in particular the application of 
degenerated primers of Non-ribosomal 
peptide synthetases (NRPS) to amplify gene 
fragments from peptide producers has 
allowed screening on the presence of non 
ribosomal peptides among secondary 
metabolite-producing microorganisms 
(Marahiel et al., 1997; Radjasa et al, 2007a).  
In this work, we reported the potential 
of marine bacteria associated with sponge 
Aaptos sp. for the production of secondary 
metabolites against Multi Drugs Resistant 
(MDR) bacterial strains coupled with PCR 
based-screening for the presence of non-
ribosomal polypeptide synthetases. 
 
 
MATERIALS AND METHODS 
 
Sampling and isolation of sponge-
associated bacteria 
 
Colonies of sponge were collected from the 
vicinity of Panjang island, Jepara, North 
Java Sea, Indonesia (Fig.1) by scuba diving. 
Upon collection sponge colonies were put 
into sterile 
 
 
Fig 1. Sampling site at Panjang island, Jepara, North Java, Indonesia
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plastic bags (Whirl-Pak, Nasco, USA. The 
tissues were then rinsed with sterile seawater 
and homogenized with blender. The 
homogenized tissues were serially diluted, 
spread on ½ strength ZoBell 2216E marine 
agar medium and incubated at room 
temperature for 48 hours. On the basis of 
morphological features, colonies were 
randomly picked and purified by making 
streak plates (Madigan et al, 2000). 
 
Antibacterial test 
 
Antibacterial test of sponge-associated 
bacteria against MDR bacteria was 
performed by using an overlay method.  
Multi Drugs Resistant (MDR) bacteria 
(Pseudomonas sp., Escherichia coli, Proteus 
sp. Enterobacter sp. and Staphylococcus sp. 
used in this study were obtained from 
Laboratory of Clinical Microbiology, 
Kariadi Hospital, Semarang). Culture of 
each MDR  bacterium in the logarithmic 
phase (ca. 109 cells ml-1) was mixed with 
TSB soft agar medium (1% v/v), which were 
then poured on to the respective agar surface 
previously inoculated with sponge-
associated bacteria and incubated for 4 d. 
The plates were then incubated at room 
temperature for 48 hours. Antibacterial 
activity was defined by the formation of 
inhibition zones around the bacterial 
colonies.  
 
PCR-based screening of NRPS 
producing bacterial strains 
 
Genomic DNA of secondary metabolite 
producing-strains for PCR analysis were 
obtained from cell materials taken from an 
agar plate, suspended in sterile water 
(Sigma, Germany) and subjected to five 
cycles of freeze (-80°C) and thaw (95°C). 
Amplification of peptide synthetase gene 
fragments was carried out with the NRPS 
degenerated primers A2gamF (5´-AAG 
GCN GGC GSB GCS TAY STG CC-3´) 
and A3gamR (5´-TTG GGB IKB CCG GTS 
GIN CCS GAG GTG-3´)(Radjasa  et al., 
2007a).  
NRPS-PCR was performed with a 
thermal cycler (Eppendorf Inc, Germany) as 
follows: 1 µl template DNA, and 1 µl of 
each of the appropriate primers, which were 
then put into puReTaq Ready-To-Go PCR 
beads (Amersham Biosciences Europe 
GmbH, Germany). A PCR run comprised 40 
cycles with denaturing conditions for one 
minute at 95°C, annealing for one minute at 
70 °C and extension for two minutes at 72 
°C, respectively. 
 
PCR amplification and sequencing of 
16S rRNA gene fragments.  
 
Amplification was conducted according to 
method of Radjasa et al (2007a). Genomic 
DNA of secondary metabolite producing-
strains for PCR analysis were obtained from 
cell materials taken from an agar plate, 
suspended in sterile water (Sigma, 
Germany) and subjected to five cycles of 
freeze (-80°C) and thaw (95°C). PCR 
amplification of partial 16S rRNA gene of 
sponge bacteria, purification of PCR 
products and subsequent sequencing 
analysis were performed according to the 
method of Radjasa et al (2007b). The 
determined DNA sequences of strains were 
then compared for homology to the BLAST 
database.  
 
 
RESULTS AND DISCUSSION 
 
Results 
 
Out of 64 sponge isolates tested, three 
isolates were found to inhibit the growth of 
3 Multi Drugs Resistant (MDR) strains 
(Table 1). 
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Table 1. Antimicrobial activity of sponge bacteria against MDR strains 
 
No Sponge Isolate MDR Strain Inhibition zone (mm) 
1 SPA1 Escherichia coli                 9.3 
2 SPA3 Escherichia coli               15.0  
3 SPA21 Proteus sp.                 8.6  
 
Further screening for the presence of 
gene fragments of Non-ribosomal Peptide 
Synthetase (NRPS) among the active 
isolates showed that all active strains were 
capable of amplifying the NRPS gene 
fragments (Fig 2.) 
 
 
 
 
 
 
                                          SPA1 SPA3 SPA21  +                   M 
  
 
 
 
 
 
Fig. 2.  PCR amplification of NRPS gene fragments;    +     control Pseudomonas 
fluorescens DSM No. 50117; M is DNA markers 
 
Molecular identification of the active sponge 
isolates based on 16S rDNA showed that the 
active strains are belonging to the members 
of Halomonas, Pseudoalteromonas and 
Alpha Proteobacterium (Table 2). 
 
Table 2. Molecular identification of active bacterial strains associated with Aaptos sp. 
 
No Bacterial 
isolate 
Closest relative Homology 
(%) 
Accession 
number 
1 SPA1 
 
Halomonas aquamarina  
 
99 DQ372908  
 
2 SPA2 
 
α-proteobacterium D21 
 
100 DQ399723 
 
3 SPA21 
 
Pseudoalteromonas luteoviolacea 
 
100 DQ504310 
 
 
Discussion 
 
Perhaps the most significant problem that 
has hampered the investigation of secondary 
metabolites produced by reef’s invertebrates 
is their low concentration.  In marine 
invertebrates many highly active compounds 
contribute to<10-6 % of the body-wet weight. 
Providing sufficient amounts of these 
biologically active substances, hence, may 
be a difficult task (Proksch et al, 2002; 
Radjasa et al 2007a, b). 
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In addition, it has often proven 
extremely difficult, and some cases 
impossible, to provide from invertebrates 
sufficient amounts of many of these 
substances due to limited amounts found in 
the producing organism, or to limited 
quantity of the organism itself, or to 
geographic, seasonal or sexual variations in 
the amounts and in the nature of produced 
secondary metabolites.  
There has been an increasing concern 
regarding the collecting reef’s organisms for 
the discovery and development of 
pharmaceuticals since it has been perceived 
variously as sustaining and threatening 
conservation. There is an urgent need to take 
into account the potential consequences of 
these activities and proposing management 
options for sustainable use of reef’s 
invertebrates as the sources of bioactive 
compounds (Sukarmi and Radjasa, 2007).  
The present study indicated that 
marine bacteria associated with sponge 
Aaptos sp. showed strong growth inhibition 
indicator microorganisms (Table 1). It is 
believed that the emergence of Multi Drugs 
Resistants (MDR) bacteria is correlated with 
improper uses of antimicrobial agents such 
as many prescriptions not taken correctly, 
antibiotics sold without medical supervision, 
and spread of resistant microbes due to the 
lack of hygiene. Considering the prevalence 
of antimicrobial resistance has emerged in 
Indonesia, the present study offers the 
possibility to use sponge bacteria as the 
source of antibacterial compounds for 
controlling the pathogenic bacteria 
especially to handle the occurrence of Multi 
Drugs Resistant (MDR) strains. 
In this study one isolate, SPA1 
showing closest relative to Halomonas 
aquamarine (Table 2) inhibited the growth 
of A. coli but not Proteus sp. (Table 1). Very 
limited information is available on the 
antibacterial activity of the member of genus 
Halomonas. Very recently, a work reported 
by Bitzer et al (2006) regarding the 
production of antibiotic 
Aminophenoxazinones produced by 
Halomonas sp. isolated from water sample 
of the East Frisian Wadden Sea. 
On the other hand, sponge bacterium 
SPA21 revealed the highest homology 
(100%) to the bacterium Pseudoalteromonas 
luteoviolacea. This bacterium inhibited the 
growth of MDR strain Proteus sp. The 
members of Alteromonadales and 
Vibrionales of the proteobacteria, such as 
Pseudoalteromonas and Vibrio have been 
known as the dominant antibiotics producers 
(Long and Azam, 2001; Grossart et al, 
2004). Futhermore, Radjasa et al (2007a) 
isolated a coral-associated bacterium 
TAB4.2 which showed 98% identity to 
Pseudoalteromonas luteoviolacea, an 
antibiotic-producing bacterium (McCarthy 
et al., 1985; Hanefeld et al., 1994) and 
exhibited growth inhibition against both 
coral bacteria and pathogenic bacteria. 
Interestingly, this coral bacterium TAB4.2 
also amplified NRPS gene fragments, and 
following DNA cloning and sequencing, a 
279 bp long DNA fragment was obtained 
and the deduced amino acid sequence 
showed conserved signature regions for 
peptide synthetases and revealed a high 
similarity to NosD (40% identity), a 
multifunctional peptide synthetase from 
Nostoc sp. GSV224, and NdaB (44% 
identity), a peptide synthetase module of 
Nodularia spumigena (Radjasa et al, 2007a). 
Species of Pseudoalteromonas have also 
been isolated from tunicates (Holmstrom, 
1998) and sponges (Ivanova et al, 2002).  
Sponge bacterium SPA3 showed high 
similarity to α-proteobacterium D21. 
Radjasa et al (2007c) isolated bacterium 
from sponge Haliclona sp. collected from 
Bandengan waters, Jepara, North Java Sea, 
which was closely related to α-
proteobacterium Z143-1 (98%), a bacterium 
isolated from Philippine tunicate that 
produce anti-Staphylococcus aureus 
metabolite heptylprodigiosin (de Guzman, 
unpublished). This result confirmed the 
presence of α-proteobacterium which was 
found to be dominantly associated with 
sponge Rhopaloides odorabile from 
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geographically different areas and, as 
specific symbiont of sponges. Furthermore, 
Webster and Hill (2001) reported that an α-
proteobacterium as found to be associated 
with sponges Theonella swinhoei, Aplysina 
aerohaba, and Haliclona panacea. 
The present study also strongly 
revealed the ecological rationale for sponge 
Aaptos sp. and its associated 
microorganisms for the maintenance of 
antimicrobial defenses. Seawaters typically 
contains 107 viruses, 106 bacteria, 103 fungi, 
and 103 microalgae/ml (Engel et al, 2002), 
including those which have been identified 
as causative agents in marine infectious 
diseases (Correa, 1997). Given that marine 
invertebrates and their symbionts are 
continuosly exposed to a broad array of 
potentially deleterious microorganisms, it is 
reasonable that the production of bioactive 
secondary metabolites could act as 
fundamental mechanism of antimicrobial 
defense. 
In conclusion, sponge Aaptos sp. 
exhibited secondary metabolite producing-
marine bacteria with antibacterial potential 
against MDR strains. Further works are 
needed to clarify the antibacterial 
compounds responsible for the growth 
inhibition toward MDR strains. 
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